Conclusion that autoimmune gastritis does not predispose to gastric cancer is unproven.

Autor: Waldum HL; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway helge.waldum@ntnu.no.

Publikováno v: Gut [Gut] 2024 Jan 05; Vol. 73 (2), pp. 379. Date of Electronic Publication: 2024 Jan 05.

Netazepide, a gastrin/CCK2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis

Autor: Boyce, M, Moore, AR, Sagatun, L, Parsons, BN, Varro, A, Campbell, F, Fossmark, R, Waldum, HL, Pritchard, DM

Publikováno v: British journal of clinical pharmacology

Netazepide, a gastrin/CCK2 receptor antagonist, once daily for 12 weeks reduced the number of tumours and size of the largest one in 16 patients with autoimmune chronic atrophic gastritis (CAG), achlorhydria, hypergastrinaemia and multiple gastric ne

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::743f431c6ed579461db112dbd5862ff4

Hypergastrinemia is associated with an increased risk of gastric adenocarcinoma with proximal location: A prospective population-based nested case-control study.

Autor: Ness-Jensen E; HUNT Research Centre, Department of Public Health and Nursing, NTNU, Norwegian University of Science and Technology, Levanger, Norway.; Department of Medicine, Levanger Hospital, Nord-Trøndelag Hospital Trust, Levanger, Norway.; Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden., Bringeland EA; Department of Gastrointestinal Surgery, St. Olav's Hospital, Trondheim University Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway., Mattsson F; Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden., Mjønes P; Department of Clinical and Molecular Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Pathology, St. Olav's Hospital, Trondheim University Hospital, Trondheim, Norway., Lagergren J; Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Grønbech JE; Department of Gastrointestinal Surgery, St. Olav's Hospital, Trondheim University Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway., Waldum HL; Department of Clinical and Molecular Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway., Fossmark R; Department of Clinical and Molecular Medicine, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Gastroenterology and Hepatology, St. Olav's Hospital, Trondheim University Hospital, Trondheim, Norway.

Publikováno v: International journal of cancer [Int J Cancer] 2021 Apr 15; Vol. 148 (8), pp. 1879-1886. Date of Electronic Publication: 2020 Nov 02.

Proton pump inhibitor use and risk of stroke: A systematic review and meta-analysis.

Autor: Yaoyao Feng¹ fengyaoyao820828@163.com, Ying Zhong¹

Publikováno v: Pakistan Journal of Medical Sciences. Nov2024, Vol. 40 Issue 10, p2432-2440. 9p.

Clinical consequences of controversies in gastric physiology.

Autor: Waldum HL; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.

Publikováno v: Scandinavian journal of gastroenterology [Scand J Gastroenterol] 2020 Jun; Vol. 55 (6), pp. 752-758. Date of Electronic Publication: 2020 Jun 09.